Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00178221
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
2EQ | 5-(5-chloro-2,4-dihydroxyphenyl)- N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole- 3-carboxamide | A | 2VCJ | 0.75 |  |
CXN | CLOXACILLIN | A,B | 1FCM | 0.72 | |
105 | N-[5-METHYL-3-O-TOLYL-ISOXAZOLE- 4-CARBOXYLIC ACID AMIDE] BORONIC ACID | A | 1JWZ | 0.77 | |
| 105 | N-[5-METHYL-3-O-TOLYL-ISOXAZOLE- 4-CARBOXYLIC ACID AMIDE] BORONIC ACID | A,B | 1FSY | 0.77 | |
| 105 | N-[5-METHYL-3-O-TOLYL-ISOXAZOLE- 4-CARBOXYLIC ACID AMIDE] BORONIC ACID | A | 1NYY | 0.77 | |
IIA | 1-{[5-(5-CHLORO-2-THIENYL)ISOXAZOL- 3-YL]METHYL}-N-(1-ISOPROPYLPIPERIDIN- 4-YL)-1H-INDOLE-2-CARBOXAMIDE | A,B | 2BOH | 0.72 | |
BI7 | 3-[(3AS,4R,8AS,8BR)-4-[5-(5-CHLORO- 2-THIENYL)ISOXAZOL-3-YL]-1,3-DIOXOOCTAHYDROPYRROLO[3,4- A]PYRROLIZIN-2(3H)-YL]-N,N,N-TRIMETHYLPROPAN- 1-AMINIUM | A | 2JKH | 0.75 | |
CXZ | 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]- 1,2-benzisoxazol-3-yl}benzene-1,3- diol | A | 3BMY | 0.7 | |
6C3 | 6-CHLORO-3-(3-METHYLISOXAZOL-5- YL)-4-PHENYLQUINOLIN-2(1H)-ONE | A | 2I0V | 0.73 | |
3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A | 2HOB | 0.78 | |
| 3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B | 2AMQ | 0.78 | |
| 3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B,C,D | 3D23 | 0.78 | |
| 3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B | 2Q6F | 0.78 | |
W33 | 5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2- OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE | 1 | 2R07 | 0.7 | |
2GG | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)- N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE- 3-CARBOXAMIDE | A | 2UWD | 0.74 | |
2GJ | 5-[2,4-DIHYDROXY-5-(1-METHYLETHYL)PHENYL]- N-ETHYL-4-[4-(MORPHOLIN-4-YLMETHYL)PHENYL]ISOXAZOLE- 3-CARBOXAMIDE | A | 2VCI | 0.73 | |
AG7 | 4-{2-(4-FLUORO-BENZYL)-6-METHYL- 5-[(5-METHYL-ISOXAZOLE-3-CARBONYL)- AMINO]-4-OXO-HEPTANOYLAMINO}-5- (2-OXO-PYRROLIDIN-3-YL)-PENTANOIC ACID ETHYL ESTER | A | 1CQQ | 0.78 | |
W43 | 5-(7-(6-CHLORO-4-(5-HYDRO-4-METHYL- 2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE | 1 | 2RM2 | 0.71 | |